- Home
- RVNC vs SSYS Comparison
RVNC vs SSYS Comparison
Compare RVNC & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- SSYS
- Stock Information
- Founded
- RVNC 1999
- SSYS 1989
- Country
- RVNC United States
- SSYS United States
- Employees
- RVNC N/A
- SSYS 1980
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- RVNC Health Care
- SSYS Technology
- Exchange
- RVNC Nasdaq
- SSYS Nasdaq
- Market Cap
- RVNC 599.6M
- SSYS 673.9M
- IPO Year
- RVNC 2014
- SSYS 1994
- Fundamental
- Price
- RVNC $3.73
- SSYS $9.44
- Analyst Decision
- RVNC Hold
- SSYS Strong Buy
- Analyst Count
- RVNC 9
- SSYS 4
- Target Price
- RVNC $9.27
- SSYS $11.50
- AVG Volume (30 Days)
- RVNC 2.9M
- SSYS 813.9K
- Earning Date
- RVNC 11-07-2024
- SSYS 11-13-2024
- Dividend Yield
- RVNC N/A
- SSYS N/A
- EPS Growth
- RVNC N/A
- SSYS N/A
- EPS
- RVNC N/A
- SSYS N/A
- Revenue
- RVNC $256,945,000.00
- SSYS $578,436,000.00
- Revenue This Year
- RVNC $20.36
- SSYS N/A
- Revenue Next Year
- RVNC $31.66
- SSYS $4.53
- P/E Ratio
- RVNC N/A
- SSYS N/A
- Revenue Growth
- RVNC 25.82
- SSYS N/A
- 52 Week Low
- RVNC $2.30
- SSYS $6.05
- 52 Week High
- RVNC $9.75
- SSYS $14.93
- Technical
- Relative Strength Index (RSI)
- RVNC 32.99
- SSYS 63.17
- Support Level
- RVNC $3.64
- SSYS $8.80
- Resistance Level
- RVNC $4.37
- SSYS $9.62
- Average True Range (ATR)
- RVNC 0.33
- SSYS 0.53
- MACD
- RVNC -0.10
- SSYS 0.10
- Stochastic Oscillator
- RVNC 14.18
- SSYS 65.68
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.